VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,924,204 | -62.1% | 205,358 | -0.7% | 0.00% | -50.0% |
Q2 2023 | $5,071,234 | +70677.9% | 206,736 | -32.9% | 0.00% | -33.3% |
Q1 2023 | $7,165 | -42.7% | 307,923 | -37.6% | 0.00% | -40.0% |
Q4 2022 | $12,496 | -99.9% | 493,722 | -12.8% | 0.01% | +25.0% |
Q3 2022 | $10,919,000 | -35.7% | 566,381 | -15.0% | 0.00% | -42.9% |
Q2 2022 | $16,969,000 | -15.3% | 666,227 | -15.7% | 0.01% | +16.7% |
Q1 2022 | $20,028,000 | -22.9% | 790,664 | +27.5% | 0.01% | -25.0% |
Q4 2021 | $25,963,000 | +78.2% | 620,065 | +85.2% | 0.01% | +100.0% |
Q3 2021 | $14,569,000 | +30.4% | 334,765 | +41.7% | 0.00% | +33.3% |
Q2 2021 | $11,170,000 | -5.7% | 236,245 | +2.2% | 0.00% | -25.0% |
Q1 2021 | $11,850,000 | +89.1% | 231,127 | -1.2% | 0.00% | +100.0% |
Q4 2020 | $6,265,000 | -44.6% | 233,941 | -29.0% | 0.00% | -50.0% |
Q3 2020 | $11,316,000 | +21.8% | 329,648 | +45.4% | 0.00% | 0.0% |
Q2 2020 | $9,287,000 | +638.8% | 226,677 | +517.6% | 0.00% | +300.0% |
Q1 2020 | $1,257,000 | +779.0% | 36,704 | +223.7% | 0.00% | – |
Q4 2019 | $143,000 | – | 11,340 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |